相关实验视频
Updated: Jul 15, 2025

10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
25.8K
探索糖尿病和心血管疾病之间的复杂联系:分析糖尿病患者减轻心血管风险的方法
Fnu Jyotsna1, Areeba Ahmed2, Kamal Kumar3
1Medicine, Dr. B. R. Ambedkar Medical College & Hospital, Mohali, IND.
Cureus
|September 25, 2023
概括
糖尿病显著增加了心血管疾病 (CVD) 风险,原因是胰岛素抵抗,高血糖和炎症. 了解这些联系是开发糖尿病患者有效预防和治疗策略的关键.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 代谢疾病 代谢疾病
背景情况:
- 心血管疾病 (CVD) 是糖尿病患者的主要死亡原因.
- 糖尿病与心血管疾病发病率和死亡率的增加密切相关.
- 胰岛素抵抗和高血糖是糖尿病与心血管疾病联系的核心因素.
研究的目的:
- 审查目前关于预防和治疗糖尿病心血管并发症的证据.
- 综合有关糖尿病和心血管疾病相关机制的文献.
- 确定减轻糖尿病患者心血管风险的策略.
主要方法:
- 最近证据的综合文学综合.
- 现有研究的叙述性审查.
- 分析包括胰岛素耐药性,脱脂症,氧化应激和炎症在内的机制.
主要成果:
- 胰岛素抵抗,高血糖,氧化压力和炎症加剧了内皮功能障碍和血管损伤.
- 糖尿病加速动脉动脉生成和动脉硬性斑块破裂,增加心肌梗塞和中风的风险.
- 糖尿病和心血管疾病之间的相互作用显著提高了心血管事件的风险.
结论:
- 充分了解糖尿病与心血管疾病之间的关系对于有效的患者管理至关重要.
- 基于证据的预防措施和治疗可以改善糖尿病患者的生活质量并降低糖尿病患者的死亡率.
- 这一综述为开发创新策略以改善糖尿病心血管结果提供了基础.
相关概念视频
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Diabetes: Management and Pharmacotherapy
302
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
302
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Coronary Artery Disease IV: Preventive Measures
23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11

